| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |